2023年度

Suzuki-Karasaki M, Ochiai Y, Innami S, Okajima H, Suzuki-Karasaki M, Nakayama H, Suzuki-Karasaki Y.
Ozone mediates the anticancer effect of air plasma by triggering oxidative cell death caused by H₂O₂ and iron.
Eur J Cell Biol. 102(4):151346, 2023.

Takeshita H, Yoshida R, Inoue J, Ishikawa K, Shinohara K, Hirayama M, Oyama T, Kubo R, Yamana K, Nagao Y, Gohara S, Sakata J, Nakashima H, Matsuoka Y, Nakamoto M, Hirayama M, Kawahara K, Takahashi N, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H.
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Lab Invest. 103(5):100060, 2023.

Iwata, H., R. Nakamura, N. Masuda, T. Yamashita, Y. Yamamoto, K. Kobayashi, J. Tsurutani, T. Iwasa, K. Yonemori, K. Tamura, T. Aruga, E. Tokunaga, K. Kaneko, M. J. Lee, A. Yuno, A. Kawabata, T. Seike, A. Kaneda, Y. Nishimura, J. B. Trepel and S. Saji
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
Jpn J Clin Oncol 53(1): 4-15, 2023

Pegna, G. J., M. J. Lee, C. J. Peer, M. I. Ahmad, D. J. Venzon, Y. Yu, A. Yuno, S. M. Steinberg, L. Cao, W. D. Figg, R. N. Donahue, R. Hassan, I. Pastan, J. B. Trepel and C. Alewine
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel. Cancer Med 12(4): 4236-4249, 2023

Uragami M, Matsushita K, Shibata Y, Takata S, Karasugi T, Sueyoshi T, Masuda T, Nakamura T, Tokunaga T, Hisanaga S, Yugami M, Sugimoto K, Yonemitsu R, Ideo K, Fukuma Y, Takata K, Arima T, Kawakami J, Maeda K, Yoshimura N, Matsunaga H, Kai Y, Tanimura S, Shimada M, Tateyama M, Miyamoto K, Kubo R, Tajiri R, Tian X, Homma F, Morinaga J, Yamanouchi Y, Takebayashi M, Kajitani N, Uehara Y, Miyamoto T
A machine learning-based scoring system and ten factors associated with hip fracture occurrence in the elderly
Bone. 2023 Nov; 176, 116865

Maeda K, Sugimoto K, Tasaki M, Taniwaki T, Arima T, Shibata Y, Tateyama M, Karasugi T, Sueyoshi T, Masuda T, Uehara Y, Tokunaga T, Hisanaga S, Yugami M, Yonemitsu R, Ideo K, Matsushita K, Fukuma Y, Uragami M, Kawakami J, Yoshimura N, Takata K, Shimada M, Tanimura S, Matsunaga H, Kai Y, Takata S, Kubo R, Tajiri R, Homma F, Tian X, Ueda M, Nakamura T, Miyamoto T
Transthyretin amyloid deposition in ligamentum flavum (LF) is significantly correlated with LF and epidural fat hypertrophy in patients with lumbar spinal stenosis
Sci. Rep. 2023 Nov 16; 13, 20019

Kasaoka S, Naito H, Uchigashima Y.
Poor Environmental Conditions Created the Acute Health Deteriorations in Evacuation Shelters after the 2016 Kumamoto Earthquake.
Tohoku J.Exp.Med. 2023 Dec;261(4):309-315.

Seki Y, Yamana K, Yoshida R, Inoue J, Shinohara K, Oyama T, Kubo R, Nagata M, Kawahara K, Hirayama M, Takahashi N, Nakamoto M, Hirosue A, Kariya R, Okada S, Nakayama H.
Programmed death-ligand 1-expressing extracellular vesicles are a prognostic factor in patients with oral squamous cell carcinoma treated with immune checkpoint inhibitors.
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.
Available online 20 December 2023.

Yamakawa N, Harada H, Nakayama H, Ohiro Y, Bukawa H, Kirita T.
Preoperative chemoradiotherapy for locally advanced oral squamous cell carcinoma: A multicenter retrospective study.
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 36(1):11-20, 2024.

Toya R, Fukugawa Y, Saito T, Matsuyama T, Yoshida R, Murakami D, Orita Y, Nakayama H, Oya N.
Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
Oral Oncol. Mar 21:151:106752, 2024.

Yamakawa N, Umeda M, Yoshii Y, Mitsudo K, Noguchi M, Kusukawa J, Katakura A, Nakayama H, Sasaki M, Noguchi T, Ueda M, Bukawa H, Yagihara K, Horie A, Miyazaki A, Chikazu D, Tomihara K, Mishima K, Otsuru M, Asoda S, Fujiwara S, Ohyama Y, Kurita H, Kawamata H, Fukuda M, Shintani Y, Kobayashi T, Kanno T, Oh-Iwa I, Kawano K, Yamashita Y, Kobayashi W, Ohiro Y, Uzawa K, Ota Y, Kirita T.
Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma. Oral Dis. Epub 2023 Jan 4; 30(2):247-258, 2024.

Ishikawa K, Matsuoka Y, Shinohara K, Inoue J, Yano H, Eto T, Yamamoto T, Yamana K, Gohara S, Takeshita H, Hirayama M, Kawahara K, Hirosue A, Fukugawa Y, Yoshida R, Komohara Y, Nakayama H.
Involvement of ferroptosis-defensive xCT/GPX4 axis in radioresistance and its impacts on prognosis in oral squamous cell carcinoma.
Oral Sci Int. 1-14, 2024.